HomeCompareMTXVX vs JNJ

MTXVX vs JNJ: Dividend Comparison 2026

MTXVX yields 0.18% · JNJ yields 3.36%● Live data

vsPost on X →
After 10 years · $10,000 invested · DRIP enabled
🏆 JNJ wins by $189.00 in total portfolio value· pulled ahead in Year 9
10 years
MTXVX
MTXVX
● Live price
0.18%
Share price
$19.06
Annual div
$0.03
5Y div CAGR
-8.9%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$19.8K
Annual income
$7.08
Full MTXVX calculator →
JNJ
Johnson & Johnson
● Live price
3.36%
Share price
$147.50
Annual div
$4.96
5Y div CAGR
5.8%
Payout ratio
55%
After 10 yrs · $10,000 · DRIP
Portfolio value
$20.0K
Annual income
$827.78
Full JNJ calculator →

Portfolio growth — MTXVX vs JNJ

📍 JNJ pulled ahead of the other in Year 9

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis PeriodMTXVXJNJ
2008–2009
GFC
— No data— No data
2020 Q1–Q2
COVID
— No data— No data
2022 Q4
Rate Hike
— No data— No data
Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.
📅

Dividend Calendar Overlap

Combined, MTXVX + JNJ cover 0 of 12 monthsgood coverage

Jan
Feb
Mar
Apr
May
Jun
Jul
Aug
Sep
Oct
Nov
Dec
MTXVX pays
JNJ pays
Both pay
Neither
💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

MTXVX
Annual income on $10K today (after 15% tax)
$15.16/yr
After 10yr DRIP, annual income (after tax)
$6.02/yr
JNJ
Annual income on $10K today (after 15% tax)
$285.83/yr
After 10yr DRIP, annual income (after tax)
$703.61/yr
At 15% tax rate, JNJ beats the other by $697.59/year in after-tax income after 10 years on $10,000
⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of MTXVX + JNJ for your $10,000?

MTXVX: 50%JNJ: 50%
100% JNJ50/50100% MTXVX
Portfolio after 10yr
$19.9K
Annual income
$417.43/yr
Blended yield
2.09%
📊

Analyst Conviction Gap

Where Wall Street is most bullish on JNJ right now

MTXVX
No analyst data
JNJ
Analyst Ratings
20
Buy
17
Hold
3
Sell
Consensus: Buy
Price Target
$228.73
+55.1% upside vs current
Range: $190.00 — $265.00
Altman Z
5.2
Piotroski
4/9
Analyst ratings via FMP. Altman Z-Score: >3.0 safe, 1.81–3.0 grey zone, <1.81 distress. Piotroski: 7–9 strong, 0–3 weak.
🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

MTXVX buys
0
JNJ buys
0
No recent congressional trades found for MTXVX or JNJ in the last 90 days.
STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →
MetricMTXVXJNJ
Forward yield0.18%3.36%
Annual dividend / share$0.03$4.96
Payout ratio50%55%
1-year div growth0%4.2%
5-year div CAGR-8.9%5.8%
Portfolio after 10y$19.8K$20.0K
Annual income after 10y$7.08$827.78
Total dividends collected$111.00$5.6K
Payment frequencyquarterlyquarterly
SectorStockHealthcare

Year-by-year: MTXVX vs JNJ ($10,000, DRIP)

YearMTXVX PortfolioMTXVX Income/yrJNJ PortfolioJNJ Income/yrGap
1$10,716$16.25$10,676$355.77+$40.00MTXVX
2$11,481$14.83$11,407$389.39+$74.00MTXVX
3$12,298$13.52$12,198$426.53+$100.00MTXVX
4$13,172$12.33$13,056$467.62+$116.00MTXVX
5$14,105$11.25$13,987$513.12+$118.00MTXVX
6$15,103$10.25$14,998$563.56+$105.00MTXVX
7$16,169$9.35$16,098$619.52+$71.00MTXVX
8$17,309$8.52$17,295$681.69+$14.00MTXVX
9← crossover$18,529$7.77$18,599$750.82$70.00JNJ
10$19,833$7.08$20,022$827.78$189.00JNJ

MTXVX vs JNJ: Complete Analysis 2026

MTXVXStock

The investment seeks current income consistent with reasonable opportunity for future growth of capital and income. The fund normally invests a minimum of 30% of its net assets in equity securities and a minimum of 30% of its net assets in debt securities. From time to time, it may temporarily invest less than 30% of its net assets in equity or debt securities as a result of market conditions, individual securities transactions or cash flow considerations. The fund may invest in investment grade and below investment grade debt securities of varying maturities.

Full MTXVX Calculator →

JNJHealthcare

Johnson & Johnson is a Dividend King with 62+ years of consecutive dividend increases. A healthcare conglomerate spanning pharmaceuticals, MedTech, and consumer health. JNJ spun off its consumer segment as Kenvue in 2023, focusing on higher-margin pharma and medical devices.

Full JNJ Calculator →
📬

Get this MTXVX vs JNJ comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

MTXVX vs SCHDMTXVX vs JEPIMTXVX vs OMTXVX vs KOMTXVX vs MAINMTXVX vs ABBVMTXVX vs MRKMTXVX vs PFE

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.